跳至主要内容
临床试验/IRCT20170420033551N12
IRCT20170420033551N12尚未招募2 期

The Effects of curcumin on clinical and metabolic signs in cigarette smokers

Kashan University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 50 years(—)
性别
All

入选标准

  • Smoking dependence (Fagerstrom test score more than 4)
  • Age of 17 to 50 years old
  • Complete informed consent

排除标准

  • Unwillingness to cooperate
  • Taking curcumin, anti-inflammatory and antioxidant supplements during the last 3 months before the intervention.
  • History of metabolic diseases including diabetes, hypertension, thyroid, and cardiovascular disease.
  • Pregnant women
  • Positive urine test for morphine, methamphetamine and cannabis
  • Use of psychiatric and neurological drugs such as benzodiazepines and antidepressants

研究者

相似试验